Michael Andrew Pfeffer, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medical Informatics | 3 | 2018 | 737 | 0.780 |
Why?
|
Hematology | 1 | 2023 | 243 | 0.670 |
Why?
|
Hematologic Diseases | 1 | 2023 | 499 | 0.650 |
Why?
|
Medical Records | 1 | 2023 | 1413 | 0.590 |
Why?
|
Medicine | 2 | 2023 | 946 | 0.510 |
Why?
|
Radiology Information Systems | 1 | 2020 | 533 | 0.500 |
Why?
|
Artificial Intelligence | 6 | 2025 | 2659 | 0.480 |
Why?
|
Radiology | 2 | 2020 | 2118 | 0.460 |
Why?
|
Demography | 1 | 2019 | 1643 | 0.450 |
Why?
|
Language | 1 | 2023 | 1557 | 0.450 |
Why?
|
Thrombosis | 2 | 2023 | 2954 | 0.420 |
Why?
|
Models, Organizational | 1 | 2016 | 546 | 0.410 |
Why?
|
Electronic Health Records | 7 | 2025 | 4877 | 0.390 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 1134 | 0.340 |
Why?
|
Documentation | 2 | 2025 | 913 | 0.300 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 591 | 0.290 |
Why?
|
Leadership | 1 | 2016 | 1395 | 0.270 |
Why?
|
Neoplasms | 3 | 2023 | 22389 | 0.250 |
Why?
|
Decision Making | 1 | 2019 | 3961 | 0.240 |
Why?
|
Academic Medical Centers | 4 | 2025 | 2785 | 0.240 |
Why?
|
Factor XI | 1 | 2023 | 34 | 0.220 |
Why?
|
Guidelines as Topic | 2 | 2019 | 1395 | 0.210 |
Why?
|
Hirudins | 1 | 2023 | 179 | 0.210 |
Why?
|
Hematologic Tests | 1 | 2023 | 240 | 0.200 |
Why?
|
Computer Security | 2 | 2023 | 260 | 0.190 |
Why?
|
Catheters | 1 | 2023 | 428 | 0.180 |
Why?
|
Research Report | 1 | 2022 | 369 | 0.160 |
Why?
|
Attitude to Computers | 1 | 2019 | 196 | 0.150 |
Why?
|
User-Computer Interface | 2 | 2025 | 1398 | 0.140 |
Why?
|
Schools, Medical | 1 | 2023 | 881 | 0.140 |
Why?
|
Cough | 1 | 2020 | 598 | 0.130 |
Why?
|
Burnout, Professional | 1 | 2025 | 712 | 0.130 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11206 | 0.130 |
Why?
|
Access to Information | 1 | 2018 | 317 | 0.120 |
Why?
|
Confidentiality | 1 | 2019 | 606 | 0.120 |
Why?
|
Perioperative Period | 1 | 2016 | 252 | 0.120 |
Why?
|
Hemorrhage | 2 | 2023 | 3456 | 0.120 |
Why?
|
Medical Record Linkage | 1 | 2016 | 286 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3253 | 0.120 |
Why?
|
Practice Management, Medical | 1 | 2016 | 191 | 0.120 |
Why?
|
Quality Improvement | 3 | 2025 | 3858 | 0.110 |
Why?
|
Physicians | 2 | 2025 | 4615 | 0.110 |
Why?
|
Organizational Objectives | 1 | 2016 | 427 | 0.110 |
Why?
|
Sex Distribution | 1 | 2018 | 2286 | 0.110 |
Why?
|
Perioperative Care | 1 | 2020 | 1046 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2023 | 1482 | 0.100 |
Why?
|
Radiation Oncology | 1 | 2018 | 573 | 0.100 |
Why?
|
Organizational Culture | 1 | 2016 | 510 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1244 | 0.100 |
Why?
|
Minority Groups | 1 | 2018 | 1215 | 0.090 |
Why?
|
Data Mining | 1 | 2016 | 561 | 0.090 |
Why?
|
Macrophages, Alveolar | 2 | 2011 | 415 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 178 | 0.090 |
Why?
|
Humans | 24 | 2025 | 768369 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 1 | 2019 | 1176 | 0.080 |
Why?
|
Computer Simulation | 1 | 2023 | 6278 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1677 | 0.080 |
Why?
|
Patient Participation | 1 | 2019 | 1450 | 0.080 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1292 | 0.080 |
Why?
|
Leukotriene B4 | 1 | 2010 | 281 | 0.080 |
Why?
|
Eicosanoids | 1 | 2011 | 284 | 0.080 |
Why?
|
Prostate-Specific Antigen | 1 | 2019 | 2483 | 0.080 |
Why?
|
Prospective Studies | 5 | 2025 | 54913 | 0.080 |
Why?
|
Anxiety | 1 | 2023 | 4655 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5308 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2020 | 3839 | 0.070 |
Why?
|
Models, Statistical | 1 | 2022 | 5103 | 0.070 |
Why?
|
Internship and Residency | 2 | 2018 | 5952 | 0.070 |
Why?
|
Lipoxins | 1 | 2010 | 419 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 586 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3384 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3941 | 0.070 |
Why?
|
California | 2 | 2021 | 1444 | 0.070 |
Why?
|
Phosphatidate Phosphatase | 1 | 2006 | 21 | 0.070 |
Why?
|
Lung Injury | 1 | 2011 | 435 | 0.070 |
Why?
|
Ambulatory Care Facilities | 2 | 2024 | 941 | 0.070 |
Why?
|
Polyisoprenyl Phosphates | 1 | 2006 | 38 | 0.060 |
Why?
|
Hospitals | 1 | 2019 | 3906 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3543 | 0.060 |
Why?
|
Docosahexaenoic Acids | 1 | 2012 | 907 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5367 | 0.060 |
Why?
|
Students, Medical | 1 | 2018 | 1962 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3267 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4340 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3230 | 0.060 |
Why?
|
Male | 11 | 2025 | 364761 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 14157 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8751 | 0.050 |
Why?
|
United States | 4 | 2024 | 73120 | 0.050 |
Why?
|
Hypersensitivity | 1 | 2012 | 1172 | 0.050 |
Why?
|
Dexamethasone | 1 | 2010 | 1965 | 0.050 |
Why?
|
Asthma | 2 | 2012 | 6274 | 0.050 |
Why?
|
Middle Aged | 8 | 2020 | 223406 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1892 | 0.050 |
Why?
|
Pilot Projects | 2 | 2025 | 8730 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 1891 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 8081 | 0.040 |
Why?
|
Workload | 1 | 2025 | 852 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2021 | 622 | 0.040 |
Why?
|
Female | 8 | 2020 | 396926 | 0.040 |
Why?
|
Stroke | 1 | 2020 | 9790 | 0.040 |
Why?
|
Los Angeles | 1 | 2017 | 245 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2017 | 301 | 0.030 |
Why?
|
Heparin | 1 | 2023 | 1636 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11859 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 81835 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1526 | 0.030 |
Why?
|
Health Care Reform | 1 | 2023 | 1256 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2023 | 6527 | 0.030 |
Why?
|
Certification | 1 | 2017 | 419 | 0.030 |
Why?
|
Data Collection | 1 | 2022 | 3329 | 0.030 |
Why?
|
Aged | 3 | 2019 | 171514 | 0.020 |
Why?
|
Hydrochloric Acid | 1 | 2011 | 76 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2023 | 5151 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2025 | 3922 | 0.020 |
Why?
|
Time Factors | 2 | 2025 | 40271 | 0.020 |
Why?
|
Adult | 6 | 2023 | 223528 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2012 | 762 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7245 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2012 | 660 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3433 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2339 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1770 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4835 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1706 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1706 | 0.020 |
Why?
|
Cytokines | 2 | 2012 | 7440 | 0.020 |
Why?
|
Internet | 1 | 2018 | 3123 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1813 | 0.020 |
Why?
|
Neutrophil Activation | 1 | 2006 | 180 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4582 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2010 | 1820 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5042 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2010 | 913 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20232 | 0.010 |
Why?
|
Curriculum | 1 | 2017 | 3778 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15879 | 0.010 |
Why?
|
Down-Regulation | 1 | 2010 | 2942 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2216 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 30031 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21552 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7955 | 0.010 |
Why?
|
Aspirin | 1 | 2012 | 3139 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10845 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3594 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11139 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39429 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 60038 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2150 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2006 | 1898 | 0.010 |
Why?
|
Macrophages | 1 | 2012 | 5797 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41782 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9508 | 0.010 |
Why?
|
Mice | 2 | 2012 | 82051 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13447 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2006 | 3076 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59679 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17637 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11928 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18390 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74915 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 22286 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15965 | 0.010 |
Why?
|
Animals | 2 | 2012 | 169424 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23639 | 0.000 |
Why?
|
Mutation | 1 | 2011 | 30235 | 0.000 |
Why?
|
Inflammation | 1 | 2006 | 10863 | 0.000 |
Why?
|